Company news

OncoSil Medical Ltd news in 2016

OncoSil Medical Ltd's news releases, calls and decks from 2016, newest first.

View company

Pancreatic cancer clinical study update

November 27, 2016

Receipt of $2.3m R & D Tax Incentive Refund

September 26, 2016

Appendix 4E - Preliminary final report 30 June 2016

August 30, 2016

Hot Calibration Run of the OncoSil Device

August 17, 2016

FDA IDE Approval

August 2, 2016

Regulatory Update June 2016

June 30, 2016

OncoSil Medical Appoints Global Sales and Marketing Director

May 17, 2016

Appendix 4C - Quarterly Cashflow

April 27, 2016

Oncosils next generation delivery platform

March 30, 2016

$10 Million Institutional Placement

February 11, 2016

US FDA Investigational Device Exemption submitted

February 10, 2016

$10 Million Institutional Placement

February 2, 2016

Decks in 2016